• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定和药理学特征研究吲达胺类胃饥饿素受体完全激动剂系列。

Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists.

机构信息

Medicinal Chemistry Department, Cardiovascular and Metabolic Diseases IMED Biotech Unit , AstraZeneca Gothenburg , 43183 Mölndal , Sweden.

Precision Medicine Laboratories, Precision Medicine and Genomics IMED Biotech Unit , AstraZeneca Gothenburg , 43183 Mölndal , Sweden.

出版信息

J Med Chem. 2018 Jul 26;61(14):5974-5987. doi: 10.1021/acs.jmedchem.8b00322. Epub 2018 Jul 6.

DOI:10.1021/acs.jmedchem.8b00322
PMID:29909635
Abstract

Cachexia and muscle wasting are very common among patients suffering from cancer, chronic obstructive pulmonary disease, and other chronic diseases. Ghrelin stimulates growth hormone secretion via the ghrelin receptor, which subsequently leads to increase of IGF-1 plasma levels. The activation of the GH/IGF-1 axis leads to an increase of muscle mass and functional capacity. Ghrelin further acts on inflammation, appetite, and adipogenesis and for this reason was considered an important target to address catabolic conditions. We report the synthesis and properties of an indane based series of ghrelin receptor full agonists; they have been shown to generate a sustained increase of IGF-1 levels in dog and have been thoroughly investigated with respect to their functional activity.

摘要

恶病质和肌肉消耗在患有癌症、慢性阻塞性肺疾病和其他慢性疾病的患者中非常常见。胃饥饿素通过胃饥饿素受体刺激生长激素分泌,随后导致 IGF-1 血浆水平升高。GH/IGF-1 轴的激活导致肌肉质量和功能能力的增加。胃饥饿素进一步作用于炎症、食欲和脂肪生成,因此被认为是解决分解代谢状态的重要靶点。我们报告了基于茚满的胃饥饿素受体完全激动剂系列的合成和性质;它们已被证明可使犬 IGF-1 水平持续升高,并已对其功能活性进行了彻底研究。

相似文献

1
Identification and Pharmacological Profile of an Indane Based Series of Ghrelin Receptor Full Agonists.鉴定和药理学特征研究吲达胺类胃饥饿素受体完全激动剂系列。
J Med Chem. 2018 Jul 26;61(14):5974-5987. doi: 10.1021/acs.jmedchem.8b00322. Epub 2018 Jul 6.
2
Identification and Optimization of Pyrrolidine Derivatives as Highly Potent Ghrelin Receptor Full Agonists.鉴定和优化吡咯烷衍生物作为强效胃饥饿素受体完全激动剂。
J Med Chem. 2020 Sep 10;63(17):9705-9730. doi: 10.1021/acs.jmedchem.0c00828. Epub 2020 Aug 27.
3
Ghrelin and cachexia: will treatment with GHSR-1a agonists make a difference for patients suffering from chronic wasting syndromes?生长激素释放肽和恶病质:生长激素促分泌素受体 1a 激动剂的治疗是否会对患有慢性消耗综合征的患者产生影响?
Mol Cell Endocrinol. 2011 Jun 20;340(1):97-105. doi: 10.1016/j.mce.2011.02.012. Epub 2011 Feb 25.
4
Identification of potent, selective, CNS-targeted inverse agonists of the ghrelin receptor.鉴定强效、选择性、中枢神经系统靶向的胃饥饿素受体反向激动剂。
Bioorg Med Chem Lett. 2013 Oct 1;23(19):5410-4. doi: 10.1016/j.bmcl.2013.07.044. Epub 2013 Jul 30.
5
Therapeutic applications of ghrelin to cachexia utilizing its appetite-stimulating effect.利用 ghrelin 的食欲刺激作用将其应用于恶病质的治疗。
Peptides. 2011 Nov;32(11):2295-300. doi: 10.1016/j.peptides.2011.05.018. Epub 2011 May 23.
6
The use of ghrelin and ghrelin receptor agonists as a treatment for animal models of disease: efficacy and mechanism.生长激素释放肽及生长激素释放肽受体激动剂治疗疾病动物模型的作用:疗效和机制。
Curr Pharm Des. 2012;18(31):4779-99. doi: 10.2174/138161212803216951.
7
A hypothesis for a possible synergy between ghrelin and exercise in patients with cachexia: Biochemical and physiological bases.关于恶病质患者中胃饥饿素与运动之间可能存在协同作用的假说:生化和生理基础。
Med Hypotheses. 2015 Dec;85(6):927-33. doi: 10.1016/j.mehy.2015.09.008. Epub 2015 Sep 12.
8
Ghrelin receptor modulators and their therapeutic potential.生长激素释放肽受体调节剂及其治疗潜力。
Future Med Chem. 2009 Apr;1(1):157-77. doi: 10.4155/fmc.09.9.
9
Activation of the ghrelin receptor is described by a privileged collective motion: a model for constitutive and agonist-induced activation of a sub-class A G-protein coupled receptor (GPCR).生长激素释放肽受体的激活被描述为一种特权集体运动:一种组成型和激动剂诱导的 A 类 G 蛋白偶联受体 (GPCR) 激活的模型。
J Mol Biol. 2010 Jan 29;395(4):769-84. doi: 10.1016/j.jmb.2009.09.051. Epub 2009 Sep 25.
10
Overlapping binding site for the endogenous agonist, small-molecule agonists, and ago-allosteric modulators on the ghrelin receptor.内源性激动剂、小分子激动剂和前变构调节剂在胃饥饿素受体上的重叠结合位点。
Mol Pharmacol. 2009 Jan;75(1):44-59. doi: 10.1124/mol.108.049189. Epub 2008 Oct 15.

引用本文的文献

1
Advances in the Development of Nonpeptide Small Molecules Targeting Ghrelin Receptor.针对胃饥饿素受体的非肽小分子的开发进展。
J Med Chem. 2022 Feb 24;65(4):3098-3118. doi: 10.1021/acs.jmedchem.1c02191. Epub 2022 Feb 14.